Named on 7 rounds in the feed, most often in Biotech.
Rounds from 2019-05-08 to 2026-09-17
ROUNDS
7
led 2, joined 5
LED ROUNDS · USD
$39M
across 2 rounds · 2 co-led, split evenly
CO-INVESTORS
31
named beside it
Named on 7 rounds in the feed, most often in Biotech.
Rounds from 2019-05-08 to 2026-09-17
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Altis Labs An AI platform for cancer trials | Series A Verified against 4 of 7 sources | $25M | 2026-09-17 | [ LEAD ] |
Umoja Biopharma Umoja Biopharma, a clinical-stage leader developing in vivo CAR T cell therapies. | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2025-01-14 | [ PART ] |
Umoja Biopharma Umoja Biopharma, a clinical-stage leader developing in vivo CAR T cell therapies. | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $210M | 2021-06-15 | [ PART ] |
LetsGetChecked LetsGetChecked sells at-home health tests, telehealth services, and pharmacy solutions to individuals and businesses. | Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2021-06-08 | [ PART ] |
Umoja Biopharma Umoja Biopharma, a clinical-stage leader developing in vivo CAR T cell therapies. | Series A Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $53M | 2020-11-18 | [ LEAD ] |
LetsGetChecked LetsGetChecked sells at-home health tests, telehealth services, and pharmacy solutions to individuals and businesses. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $71M | 2020-05-06 | [ PART ] |
LetsGetChecked LetsGetChecked sells at-home health tests, telehealth services, and pharmacy solutions to individuals and businesses. | Series B Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $30M | 2019-05-08 | [ PART ] |